AJMC July 25, 2024
MCED: Tests May Have a Role in Health Equity, but We’re Not There Yet
If you ask experts about low rates of next-generation sequencing (NGS) and what can be done to improve testing levels to fulfill the promise of precision medicine, it’s a good bet someone will bring up multicancer early detection (MCED), the blood tests that offer the possibility of finding the first cells of cancer in the body.
This is a concept that many like in theory, but the US oncology care system is a long way from offering these tests to patients on a widespread basis, according to panelists of the session, “Multicancer Detection: Is it Ready for Prime Time?” The packed session took place on the...
Today's Sponsors
Today's Sponsor